Compare FEIM & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FEIM | HBIO |
|---|---|---|
| Founded | 1961 | 1901 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 348.4M | 33.8M |
| IPO Year | N/A | 2000 |
| Metric | FEIM | HBIO |
|---|---|---|
| Price | $57.01 | $0.73 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $42.50 | $2.50 |
| AVG Volume (30 Days) | 308.0K | ★ 682.2K |
| Earning Date | 12-11-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 163.76 | N/A |
| EPS | ★ 2.17 | N/A |
| Revenue | $69,852,000.00 | ★ $87,371,000.00 |
| Revenue This Year | $5.52 | N/A |
| Revenue Next Year | $17.07 | $7.22 |
| P/E Ratio | $26.11 | ★ N/A |
| Revenue Growth | ★ 16.06 | N/A |
| 52 Week Low | $13.69 | $0.28 |
| 52 Week High | $59.38 | $2.28 |
| Indicator | FEIM | HBIO |
|---|---|---|
| Relative Strength Index (RSI) | 81.66 | 53.17 |
| Support Level | $41.11 | $0.71 |
| Resistance Level | $54.45 | $0.80 |
| Average True Range (ATR) | 4.42 | 0.06 |
| MACD | 2.06 | -0.01 |
| Stochastic Oscillator | 90.52 | 28.35 |
Frequency Electronics Inc is engaged in the design, development, and manufacture of high-precision timing, and frequency control products for space, air, sea, and terrestrial applications. The company has FEI-NY and FEI-Zyfer reportable segments. It derives the majority of its revenues from the FEI-NY segment. FEI-NY segment operations consist principally of precision time and frequency control products used in three principal markets namely communication satellites (both commercial and U.S. Government-funded); terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.